Clinical trial
Cancer DNA Screening Pilot Study (CANDACE)
NCT02808884 is registered in ClinicalTrials.gov with British Columbia Cancer Agency as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cancer DNA Screening Pilot Study (CANDACE)
- Lead sponsor
- British Columbia Cancer Agency
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 19, 2016
- Completion date
- June 10, 2019
- Enrollment
- 1,514 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
circulating tumor cells